Largest pharmaceuticals by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

AbbVie leads the 35 pharmaceuticals ranked by total debt, at SAR 253.2B, ahead of Pfizer (SAR 243B) and Merck & Co (SAR 184.9B). Figures as of 18 Nov 2026, 14:31 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
35
First
AbbVieSAR 253.2B
Median
SAR 19.8B
Combined market value
SAR 19.19T
Countries
10
Not ranked
26no total debt on file

Market values as of .

Largest pharmaceuticals by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health CareSAR 253.2BSAR 1.92TSAR 1,087.41 1.01% down 26% up United States
2PfizerPFE · Health CareSAR 243BSAR 604.5BSAR 106.05 0.66% down 14% up United States
3Merck & CoMRK · Health CareSAR 184.9BSAR 1.31TSAR 530.17 1.44% down 51% up United States
4Johnson & JohnsonJNJ · Health CareSAR 179.8BSAR 2.49TSAR 1,035.41 1.00% down 38% up United States
5Bristol-Myers SquibbBMY · Health CareSAR 169.2BSAR 465.7BSAR 227.84 1.04% down 34% up United States
6Eli LillyLLY · Health CareSAR 159.4BSAR 4.7TSAR 5,277.43 0.60% down 35% up United States
7Takeda PharmaceuticalTAK · Health CareSAR 114.7BSAR 257.2BSAR 80.50 0.85% down 54% up Japan
8AstraZenecaAZN · Health CareSAR 111.1BSAR 1.05TSAR 674.73 1.28% down 2% up United Kingdom
9NovartisNVS · Health CareSAR 107.8BSAR 1.11TSAR 588.83 1.37% down 25% up Switzerland
10SanofiSNY · Health CareSAR 77.8BSAR 426.1BSAR 177.44 0.47% down 4% down France
11Novo NordiskNVO · Health CareSAR 72.9BSAR 663.8BSAR 150.60 1.36% down 17% down Denmark
12GSKGSK · Health CareSAR 72BSAR 367.8BSAR 183.50 0.62% down 6% up United Kingdom
13ViatrisVTRS · Health CareSAR 54.1BSAR 88.2BSAR 76.90 0.24% up 96% up United States
14Abbott LaboratoriesABT · Health CareSAR 48.5BSAR 680.2BSAR 392.77 2.55% down 17% down United States
15ZoetisZTS · Health CareSAR 33.9BSAR 125.5BSAR 308.95 1.34% down 29% down United States
16Royalty PharmaRPRX · Health CareSAR 33.6BSAR 147.6BSAR 256.66 0.37% down 78% up United States
17Jazz PharmaceuticalsJAZZ · Health CareSAR 20.1BSAR 57.8BSAR 900.62 0.25% down 37% up Ireland
18GenmabGMAB · Health CareSAR 19.8BSAR 119.3BSAR 193.44 0.75% down 70% up Denmark
19Elanco Animal HealthELAN · Health CareSAR 15.1BSAR 48.4BSAR 96.81 0.15% down 20% up United States
20Amneal PharmaceuticalsAMRX · Health CareSAR 9.6BSAR 27.6BSAR 79.22 0.00% 83% up United States
21BridgeBio PharmaBBIO · Health CareSAR 7.5BSAR 55.9BSAR 286.95 0.39% down 17% up United States
22Regeneron PharmaceuticalsREGN · Health CareSAR 7.4BSAR 369.5BSAR 3,571.44 0.59% down 36% up United States
23Ionis PharmaceuticalsIONS · Health CareSAR 6.8BSAR 16.7BSAR 100.36 0.76% down 64% down United States
24BeOne MedicinesONC · Health CareSAR 3.9BSAR 174.3BSAR 1,525.84 1.57% down 17% up Switzerland
25Ascendis PharmaASND · Health CareSAR 3BSAR 66.1BSAR 1,007.01 1.00% down 28% up Denmark
26InsmedINSM · Health CareSAR 2.1BSAR 99.6BSAR 453.87 0.71% down 40% down United States
27Madrigal PharmaceuticalsMDGL · Health CareSAR 1.3BSAR 36.7BSAR 1,579.64 0.20% down 24% down United States
28Legend BiotechLEGN · Health CareSAR 1.2BSAR 11.8BSAR 60.58 0.25% up 42% down United States
29CytokineticsCYTK · Health CareSAR 1.1BSAR 27.1BSAR 194.68 0.48% up 20% down United States
30TG TherapeuticsTGTX · Health CareSAR 921.4MSAR 35.4BSAR 234.25 0.41% down 107% up United States
31Cogent BiosciencesCOGT · Health CareSAR 836.1MSAR 18.4BSAR 105.52 1.01% up 20% down United States
32Dr. Reddy's LaboratoriesRDY · Health CareSAR 726.7MSAR 46.2BSAR 55.40 0.20% down 5% up India
33Axsome TherapeuticsAXSM · Health CareSAR 704.2MSAR 26.9BSAR 512.01 0.40% up 7% down United States
34Rhythm PharmaceuticalsRYTM · Health CareSAR 405.8MSAR 30.1BSAR 434.07 0.76% down 13% up United States
35Definium TherapeuticsDFTX · Health CareSAR 152.2MSAR 15BSAR 109.53 0.61% down 169% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 26 companies have no total debt on file and are not ranked here.

Questions and answers

Which pharmaceuticals rank first by total debt?

AbbVie (SAR 253.2B), Pfizer (SAR 243B) and Merck & Co (SAR 184.9B) are the top three of the 35 pharmaceuticals ranked by total debt as of 18 Nov 2026, 14:31 UTC.

How many pharmaceuticals are in this ranking?

35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.

What are these pharmaceuticals worth together?

The 35 pharmaceuticals ranked by total debt have a combined market value of SAR 19.19T as of 18 Nov 2026, 14:31 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest pharmaceuticals by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.